OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Amyloid, tau, pathogen infection and antimicrobial protection in Alzheimer’s disease –conformist, nonconformist, and realistic prospects for AD pathogenesis
Hongmei Li, Chia‐Chen Liu, Hui Zheng, et al.
Translational Neurodegeneration (2018) Vol. 7, Iss. 1
Open Access | Times Cited: 90
Hongmei Li, Chia‐Chen Liu, Hui Zheng, et al.
Translational Neurodegeneration (2018) Vol. 7, Iss. 1
Open Access | Times Cited: 90
Showing 1-25 of 90 citing articles:
Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
Jiaqi Liu, Qing Xiao, Jiani Xiao, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 1126
Jiaqi Liu, Qing Xiao, Jiani Xiao, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 1126
Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease
Tiantian Guo, Denghong Zhang, Yuzhe Zeng, et al.
Molecular Neurodegeneration (2020) Vol. 15, Iss. 1
Open Access | Times Cited: 669
Tiantian Guo, Denghong Zhang, Yuzhe Zeng, et al.
Molecular Neurodegeneration (2020) Vol. 15, Iss. 1
Open Access | Times Cited: 669
Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing
Stephen C. Cunnane, Eugenia Trushina, Cecilie Morland, et al.
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 9, pp. 609-633
Open Access | Times Cited: 653
Stephen C. Cunnane, Eugenia Trushina, Cecilie Morland, et al.
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 9, pp. 609-633
Open Access | Times Cited: 653
Restoring Wnt/β-catenin signaling is a promising therapeutic strategy for Alzheimer’s disease
Lin Jia, Juan C. Piña‐Crespo, Yonghe Li
Molecular Brain (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 221
Lin Jia, Juan C. Piña‐Crespo, Yonghe Li
Molecular Brain (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 221
Time to test antibacterial therapy in Alzheimer’s disease
Francesco Panza, Madia Lozupone, Vincenzo Solfrizzi, et al.
Brain (2019)
Open Access | Times Cited: 139
Francesco Panza, Madia Lozupone, Vincenzo Solfrizzi, et al.
Brain (2019)
Open Access | Times Cited: 139
Brain‐Penetration and Neuron‐Targeting DNA Nanoflowers Co‐Delivering miR‐124 and Rutin for Synergistic Therapy of Alzheimer's Disease
Qin Ouyang, Kai Liu, Qubo Zhu, et al.
Small (2022) Vol. 18, Iss. 14
Closed Access | Times Cited: 61
Qin Ouyang, Kai Liu, Qubo Zhu, et al.
Small (2022) Vol. 18, Iss. 14
Closed Access | Times Cited: 61
The Unifying Hypothesis of Alzheimer’s Disease: Heparan Sulfate Proteoglycans/Glycosaminoglycans Are Key as First Hypothesized Over 30 Years Ago
Alan D. Snow, Joel A. Cummings, Thomas P. Lake
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 60
Alan D. Snow, Joel A. Cummings, Thomas P. Lake
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 60
Pharmacological activities and pharmacokinetics of liquiritin: A review
Junyuan Qin, Junren Chen, Peng Fu, et al.
Journal of Ethnopharmacology (2022) Vol. 293, pp. 115257-115257
Closed Access | Times Cited: 59
Junyuan Qin, Junren Chen, Peng Fu, et al.
Journal of Ethnopharmacology (2022) Vol. 293, pp. 115257-115257
Closed Access | Times Cited: 59
Non-Invasive Drug Delivery across the Blood–Brain Barrier: A Prospective Analysis
Sarfaraz K. Niazi
Pharmaceutics (2023) Vol. 15, Iss. 11, pp. 2599-2599
Open Access | Times Cited: 35
Sarfaraz K. Niazi
Pharmaceutics (2023) Vol. 15, Iss. 11, pp. 2599-2599
Open Access | Times Cited: 35
N-Glycan Profile of Cerebrospinal Fluids from Alzheimer’s Disease Patients Using Liquid Chromatography with Mass Spectrometry
Byeong Gwan Cho, Lucas Veillon, Yehia Mechref
Journal of Proteome Research (2019) Vol. 18, Iss. 10, pp. 3770-3779
Open Access | Times Cited: 55
Byeong Gwan Cho, Lucas Veillon, Yehia Mechref
Journal of Proteome Research (2019) Vol. 18, Iss. 10, pp. 3770-3779
Open Access | Times Cited: 55
“Amyloid‐beta accumulation cycle” as a prevention and/or therapy target for Alzheimer's disease
Chinthalapally V. Rao, Adam S. Asch, Daniel J.J. Carr, et al.
Aging Cell (2020) Vol. 19, Iss. 3
Open Access | Times Cited: 53
Chinthalapally V. Rao, Adam S. Asch, Daniel J.J. Carr, et al.
Aging Cell (2020) Vol. 19, Iss. 3
Open Access | Times Cited: 53
Amyloid-β: A double agent in Alzheimer's disease?
Hao Yu, Jie Wu
Biomedicine & Pharmacotherapy (2021) Vol. 139, pp. 111575-111575
Open Access | Times Cited: 43
Hao Yu, Jie Wu
Biomedicine & Pharmacotherapy (2021) Vol. 139, pp. 111575-111575
Open Access | Times Cited: 43
Targeting epigenetics: A novel promise for Alzheimer’s disease treatment
Danko Jeremic, Lydia Jiménez‐Díaz, Juan D. Navarro‐López
Ageing Research Reviews (2023) Vol. 90, pp. 102003-102003
Closed Access | Times Cited: 15
Danko Jeremic, Lydia Jiménez‐Díaz, Juan D. Navarro‐López
Ageing Research Reviews (2023) Vol. 90, pp. 102003-102003
Closed Access | Times Cited: 15
A Nanozyme-Boosted MOF-CRISPR Platform for Treatment of Alzheimer’s Disease
Jie Yang, Geng Qin, Zhenqi Liu, et al.
Nano Letters (2024) Vol. 24, Iss. 32, pp. 9906-9915
Closed Access | Times Cited: 6
Jie Yang, Geng Qin, Zhenqi Liu, et al.
Nano Letters (2024) Vol. 24, Iss. 32, pp. 9906-9915
Closed Access | Times Cited: 6
TFR1 knockdown alleviates iron overload and mitochondrial dysfunction during neural differentiation of Alzheimer’s disease-derived induced pluripotent stem cells by interacting with GSK3B
Tao Kang, Zheng Han, Li‐Juan Zhu, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 5
Tao Kang, Zheng Han, Li‐Juan Zhu, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 5
Exploring the role of T cells in Alzheimer's and other neurodegenerative diseases: Emerging therapeutic insights from the T Cells in the Brain symposium
Wassim Elyaman, Lawrence J. Stern, Ning Jiang, et al.
Alzheimer s & Dementia (2025)
Open Access
Wassim Elyaman, Lawrence J. Stern, Ning Jiang, et al.
Alzheimer s & Dementia (2025)
Open Access
Alzheimer’s dementia: pathogenesis and impact of cardiovascular risk factors on cognitive decline
Pitchaya Wanleenuwat, Piotr Iwanowski, Wojciech Kozubski
Postgraduate Medicine (2019) Vol. 131, Iss. 7, pp. 415-422
Closed Access | Times Cited: 49
Pitchaya Wanleenuwat, Piotr Iwanowski, Wojciech Kozubski
Postgraduate Medicine (2019) Vol. 131, Iss. 7, pp. 415-422
Closed Access | Times Cited: 49
Targeting the Wnt/β-catenin pathway in neurodegenerative diseases: recent approaches and current challenges
Annalucia Serafino, Daniela Giovannini, Simona Rossi, et al.
Expert Opinion on Drug Discovery (2020) Vol. 15, Iss. 7, pp. 803-822
Closed Access | Times Cited: 47
Annalucia Serafino, Daniela Giovannini, Simona Rossi, et al.
Expert Opinion on Drug Discovery (2020) Vol. 15, Iss. 7, pp. 803-822
Closed Access | Times Cited: 47
The role of microbial infection in the pathogenesis of Alzheimer’s disease and the opportunity for protection by anti-microbial peptides
Feijie Li, Milton T. W. Hearn, Louise E. Bennett
Critical Reviews in Microbiology (2021) Vol. 47, Iss. 2, pp. 240-253
Closed Access | Times Cited: 32
Feijie Li, Milton T. W. Hearn, Louise E. Bennett
Critical Reviews in Microbiology (2021) Vol. 47, Iss. 2, pp. 240-253
Closed Access | Times Cited: 32
Incident Herpes Zoster and Risk of Dementia
Sigrún Alba Jóhannesdóttir Schmidt, Katalin Veres, Henrik Toft Sørensen, et al.
Neurology (2022) Vol. 99, Iss. 7
Open Access | Times Cited: 22
Sigrún Alba Jóhannesdóttir Schmidt, Katalin Veres, Henrik Toft Sørensen, et al.
Neurology (2022) Vol. 99, Iss. 7
Open Access | Times Cited: 22
Mesoporous silica nanoparticle-encapsulated Bifidobacterium attenuates brain Aβ burden and improves olfactory dysfunction of APP/PS1 mice by nasal delivery
Ni Liu, Changwen Yang, Xiaohan Liang, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 22
Ni Liu, Changwen Yang, Xiaohan Liang, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 22
Multifunctional Nanocarriers for Alzheimer’s Disease: Befriending the Barriers
Mohammad Azam Ansari, Takshashila Tripathi, Baskar Venkidasamy, et al.
Molecular Neurobiology (2023) Vol. 61, Iss. 5, pp. 3042-3089
Closed Access | Times Cited: 13
Mohammad Azam Ansari, Takshashila Tripathi, Baskar Venkidasamy, et al.
Molecular Neurobiology (2023) Vol. 61, Iss. 5, pp. 3042-3089
Closed Access | Times Cited: 13
Nanomaterials that Aid in the Diagnosis and Treatment of Alzheimer's Disease, Resolving Blood–Brain Barrier Crossing Ability
Qingting Song, Junyou Li, Ting Li, et al.
Advanced Science (2024) Vol. 11, Iss. 38
Open Access | Times Cited: 4
Qingting Song, Junyou Li, Ting Li, et al.
Advanced Science (2024) Vol. 11, Iss. 38
Open Access | Times Cited: 4
Advances in amyloid beta oligomer detection applications in Alzheimer's disease
Angelo Jamerlan, Seong Soo A. An, John Hulme
TrAC Trends in Analytical Chemistry (2020) Vol. 129, pp. 115919-115919
Closed Access | Times Cited: 35
Angelo Jamerlan, Seong Soo A. An, John Hulme
TrAC Trends in Analytical Chemistry (2020) Vol. 129, pp. 115919-115919
Closed Access | Times Cited: 35
Quantitative Study of the Changes in Cerebral Blood Flow and Iron Deposition During Progression of Alzheimer’s Disease
Dongxue Li, Yuancheng Liu, Xianchun Zeng, et al.
Journal of Alzheimer s Disease (2020) Vol. 78, Iss. 1, pp. 439-452
Closed Access | Times Cited: 35
Dongxue Li, Yuancheng Liu, Xianchun Zeng, et al.
Journal of Alzheimer s Disease (2020) Vol. 78, Iss. 1, pp. 439-452
Closed Access | Times Cited: 35
